Christophe Denoyelle

Title: Christophe Denoyelle: Innovator in Ovarian Carcinoma Research

Introduction

Christophe Denoyelle is a notable inventor based in Saint-Germain-sous-Cailly, France. He has made significant contributions to the field of medical research, particularly in the area of ovarian carcinoma. His work focuses on the identification of biomarkers that can aid in the diagnosis and prognosis of high-grade serous ovarian carcinoma.

Latest Patents

Denoyelle holds a patent titled "Predictive and prognostic use of a miRNA for high grade serous ovarian carcinoma therapeutic care." This patent relates to the identification of a circulating miRNA biomarker that is suitable for use in diagnosing and prognosticating high-grade serous ovarian carcinoma (HGSOC). The patent also includes the development of diagnostic kits designed for such purposes. He has 1 patent to his name.

Career Highlights

Throughout his career, Denoyelle has worked with esteemed institutions such as Université de Caen Normandie and the Institut National de la Santé et de la Recherche Médicale. His research has contributed to advancements in therapeutic care for ovarian cancer patients.

Collaborations

Denoyelle has collaborated with notable colleagues, including Nicolas Vigneron and Laurent Poulain. Their combined expertise has furthered the understanding of miRNA's role in cancer diagnostics.

Conclusion

Christophe Denoyelle's innovative work in the field of ovarian carcinoma research highlights the importance of biomarkers in medical diagnostics. His contributions continue to pave the way for improved therapeutic strategies in cancer care.